Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02418793
What this trial is testing

A Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
OPKO Health, Inc. 27
Large-scale testing (Phase 3)Active Not RecruitingNCT05606614
What this trial is testing

A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)

Who this might be right for
Rett Syndrome
Taysha Gene Therapies, Inc. 17
Very early researchLooking for participantsNCT06822998
What this trial is testing

HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
HighField Biopharmaceuticals Corporation 10
Early research (Phase 1)Study completedNCT01682187
What this trial is testing

A Dose-Escalation Study in Participants With Recurrent Malignant Glioma

Who this might be right for
Glioma
Eli Lilly and Company 66
Early research (Phase 1)WithdrawnNCT05043987
What this trial is testing

Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers

Who this might be right for
Pancreatic CancerGastric Cancer
Conjupro Biotherapeutics, Inc.
Early research (Phase 1)Study completedNCT06718998
What this trial is testing

A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or Obesity

Who this might be right for
Obesity
Novo Nordisk A/S 134
Early research (Phase 1)Ended earlyNCT06194877
What this trial is testing

Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

Who this might be right for
Colorectal CancerPancreatic Ductal CancerAdvanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers
MapKure, LLC 13
Early research (Phase 1)Study completedNCT01233895
What this trial is testing

Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sanofi 26
Early research (Phase 1)Not Yet RecruitingNCT06866795
What this trial is testing

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Geode Therapeutics Inc. 42
Testing effectiveness (Phase 2)Study completedNCT01014975
What this trial is testing

A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

Who this might be right for
Acute Ischemic Stroke
Grifols Therapeutics LLC 40
Post-approval studies (Phase 4)Study completedNCT06310057
What this trial is testing

Tofacitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Dose Escalation Study

Who this might be right for
Axial Spondyloarthritis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778446
What this trial is testing

Test CRT-402 in Refractory Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErythematosusSystemic Scleroderma+1 more
Myeloid Therapeutics 34
Early research (Phase 1)Looking for participantsNCT06088888
What this trial is testing

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Shenzhen TargetRx Co., Ltd. 90
Testing effectiveness (Phase 2)Looking for participantsNCT07460375
What this trial is testing

Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 191
Early research (Phase 1)Looking for participantsNCT06563375
What this trial is testing

Phase 1 Dose Escalation and Dose Expansion Trial of NP-101 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
M.D. Anderson Cancer Center 35
Early research (Phase 1)Ended earlyNCT02151357
What this trial is testing

Safety, Tolerability and Pharmacokinetics of DCBCI0901 in Patients With Advanced Solid Tumor

Who this might be right for
Cancer
Standard Chem. & Pharm. Co., Ltd. 17
Early research (Phase 1)Looking for participantsNCT06046495
What this trial is testing

The Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Avistone Biotechnology Co., Ltd. 81
Early research (Phase 1)Ended earlyNCT02082977
What this trial is testing

Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma, Transformed Follicular Lymphoma, Other Non-Hodgkin's Lymphomas, Solid Tumors and Multiple Myeloma

Who this might be right for
CancerNeoplasms
GlaxoSmithKline 41
Testing effectiveness (Phase 2)Ended earlyNCT05159388
What this trial is testing

PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody) in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Servier Bio-Innovation LLC 46
Early research (Phase 1)Ended earlyNCT00725062
What this trial is testing

Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Masonic Cancer Center, University of Minnesota 3
Next Page